BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26549347)

  • 1. Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors.
    Semenza GL
    Mol Aspects Med; 2016; 47-48():15-23. PubMed ID: 26549347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.
    Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK
    Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells.
    Bae D; Mondragon-Teran P; Hernandez D; Ruban L; Mason C; Bhattacharya SS; Veraitch FS
    Stem Cells Dev; 2012 May; 21(8):1344-55. PubMed ID: 21875341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From stem cells to cancer stem cells: HIF takes the stage.
    Lee KE; Simon MC
    Curr Opin Cell Biol; 2012 Apr; 24(2):232-5. PubMed ID: 22296771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and HIFs in regulating the development of the hematopoietic system.
    Imanirad P; Dzierzak E
    Blood Cells Mol Dis; 2013 Dec; 51(4):256-63. PubMed ID: 24103835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
    Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
    Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
    Semenza GL
    Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent and Multipotent Stem Cells Display Distinct Hypoxic miRNA Expression Profiles.
    Agrawal R; Dale TP; Al-Zubaidi MA; Benny Malgulwar P; Forsyth NR; Kulshreshtha R
    PLoS One; 2016; 11(10):e0164976. PubMed ID: 27783707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the hypoxia response system in hematopoietic and leukemic stem cells.
    Takubo K; Suda T
    Int J Hematol; 2012 May; 95(5):478-83. PubMed ID: 22539363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-renewal and pluripotency is maintained in human embryonic stem cells by co-culture with human fetal liver stromal cells expressing hypoxia inducible factor 1alpha.
    Ji L; Liu YX; Yang C; Yue W; Shi SS; Bai CX; Xi JF; Nan X; Pei XT
    J Cell Physiol; 2009 Oct; 221(1):54-66. PubMed ID: 19492421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Assays of Breast Cancer Stem Cells.
    Samanta D; Semenza GL
    Methods Mol Biol; 2018; 1742():237-246. PubMed ID: 29330805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
    Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
    Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance.
    Li Z; Rich JN
    Curr Top Microbiol Immunol; 2010; 345():21-30. PubMed ID: 20582533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factors in cancer stem cells and inflammation.
    Peng G; Liu Y
    Trends Pharmacol Sci; 2015 Jun; 36(6):374-83. PubMed ID: 25857287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications.
    Staal FJ; Baum C; Cowan C; Dzierzak E; Hacein-Bey-Abina S; Karlsson S; Lapidot T; Lemischka I; Mendez-Ferrer S; Mikkers H; Moore K; Moreno E; Mummery CL; Robin C; Suda T; Van Pel M; Vanden Brink G; Zwaginga JJ; Fibbe WE
    Leukemia; 2011 Jul; 25(7):1095-102. PubMed ID: 21527933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of TGF-β family signals in the fate determination of pluripotent stem cells.
    Itoh F; Watabe T; Miyazono K
    Semin Cell Dev Biol; 2014 Aug; 32():98-106. PubMed ID: 24910449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plethora of human pluripotent stem cells.
    Gao L; Thilakavathy K; Nordin N
    Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.